Global Medical REIT Inc. (GMRE)
NYSE: GMRE · Real-Time Price · USD
8.78
+0.04 (0.40%)
Mar 31, 2025, 2:31 PM EDT - Market open
Global Medical REIT Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Global Medical REIT stock have an average target of 10.88, with a low estimate of 10 and a high estimate of 11.75. The average target predicts an increase of 23.99% from the current stock price of 8.78.
Analyst Consensus: Strong Buy
* Price targets were last updated on Oct 18, 2024.
Analyst Ratings
The average analyst rating for Global Medical REIT stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citizens Capital Markets | Citizens Capital Markets | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Mar 12, 2025 |
| Berenberg | Berenberg | Strong Buy Initiates $12 | Strong Buy | Initiates | $12 | +33.90% | Oct 18, 2024 |
| B. Riley Securities | B. Riley Securities | Strong Buy Maintains $11 → $10 | Strong Buy | Maintains | $11 → $10 | +13.96% | May 13, 2024 |
| B. Riley Securities | B. Riley Securities | Strong Buy Maintains $12 → $11 | Strong Buy | Maintains | $12 → $11 | +25.36% | May 8, 2023 |
| B. Riley Securities | B. Riley Securities | Strong Buy Maintains $14 → $12 | Strong Buy | Maintains | $14 → $12 | +36.75% | Mar 6, 2023 |
Financial Forecast
Revenue This Year
147.71M
from 138.76M
Increased by 6.45%
Revenue Next Year
152.30M
from 147.71M
Increased by 3.11%
EPS This Year
0.12
from 0.01
Increased by 895.20%
EPS Next Year
0.06
from 0.12
Decreased by -50.00%
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 162.0M | 167.9M | 163.3M | |
| Avg | 147.7M | 152.3M | 153.8M | |
| Low | 136.2M | 139.3M | 143.2M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 16.7% | 13.7% | 7.2% | |
| Avg | 6.4% | 3.1% | 1.0% | |
| Low | -1.9% | -5.7% | -6.0% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 0.17 | 0.06 | 0.09 |
| Avg | 0.12 | 0.06 | 0.09 |
| Low | 0.08 | 0.06 | 0.09 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 1,266.0% | -48.5% | 54.4% |
| Avg | 895.2% | -50.0% | 50.0% |
| Low | 537.5% | -52.0% | 44.1% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.